Validation of a high-performance liquid chromatographic assay for the quantification of Reovirus particles type 3

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 3, 2007, Pages 417-421

  Chahal, Parminder Singh ^a   Transfiguracion, Julia ^a   Bernier, Alice ^a   Voyer, Robert ^a   Coffey, Matt ^b   Kamen, Amine ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b ONCOLYTICS BIOTECH INC   (Canada)

Author keywords

HPLC; Oncolytics; Quantification; Reovirus; Validation

Indexed keywords

ACCURACY; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; REOVIRUS; VALIDATION PROCESS; VIRUS PURIFICATION;

ANION EXCHANGE RESINS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MAMMALIAN ORTHOREOVIRUS 3; PARTICLE SIZE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUTIONS;

EID: 35348951578     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.06.025     Document Type: Article

References (9)

1. Duncan M.R., Stanish S.M., and Cox D.C. J. Virol. 28 (1978) 444-449
2. Hashiro G., Loh P.C., and Yau J.T. Arch. Virol. 54 (1977) 307-315
3. International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of analytical procedures: Methodology, ICH-Q2B, Geneva, 1996.
4. International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of analytical procedures: Text and Methodology, ICH-Q2(R1), Current Step 4 version, Geneva, 2005.
5. US FDA Technical Review Guide: Validation of Chromatographic Methods, Center for Drug Evaluation and Research (CDER), Rockville, MD, 1993.
6. Szepesi G., Gazdag M., and Mihalyfi K. J. Chromatogr. 464 (1989) 265-278
7. Ritter N.M., Hayes T., and Dougherty J. J. Biomol. Technol. 12 (2001) 11-15
8. Smith R.E., Zweerink H.J., and Joklik W.K. Virology 39 (1969) 791-810
9. Coombs K.M. Virology 243 (1998) 218-228